Clinical trial
Safety and Efficacy of Sustained Erythropoietin Therapy of Anemia in End Stage Renal Disease (ESRD) Dialysis Patients Using EPODURE Biopump
NCT01555515 is registered in ClinicalTrials.gov with Medgenics Medical Israel Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Sustained Erythropoietin Therapy of Anemia in End Stage Renal Disease (ESRD) Dialysis Patients Using EPODURE Biopump
- Lead sponsor
- Medgenics Medical Israel Ltd.
- Phase
- Phase 1/2
- Overall status
- Terminated
- Start date
- March 31, 2012
- Completion date
- April 30, 2014
- Enrollment
- 4 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
anemia, end stage renal disease